Condition: Alcohol Use Disorder · Opioid Use Disorder · Alcohol Use · Sponsor: University of Notre Dame
This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.
This description comes directly from the study's public registry record.
Ryan Carpenter, PhD · +1 574-631-5429 · ryancarpenter@nd.edu
Beth A Arnold, M.S. · 574-213-2096 · bhanawal@nd.edu
Always discuss trial participation with your own doctor first.
| The University of Notre Dame | Notre Dame, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07342504